The Natural Progression of Kidney Injury in Young Type 1 Diabetic Patients

Overview

Journal Curr Diab Rep

Publisher Current Science

Specialty Endocrinology

Date 2009 Dec 4

PMID 19954694

Citations 8

Authors

Julia M Steinke

Affiliations

Soon will be listed here.

Abstract

Diabetes is the most common cause of end-stage renal disease in industrialized countries. This article describes the structural changes in early diabetic nephropathy and the relationship with renal functional parameters, blood pressure, and albumin excretion. The detrimental influence of sustained hyperglycemia and/or glycemic fluctuations on renal structural change has been well documented. Tight glycemic control is paramount to preventing the development, and even the regression, of renal lesions. As much of the renal injury from diabetes occurs in clinical silence before symptoms or laboratory findings of renal injury are evident, finding early markers of risk is imperative so that nephropathy can be prevented. Currently, the only clinical surrogate marker of diabetic renal injury available is microalbuminuria. However, given the reports of regression of microalbuminuria back to normoalbuminuria, the reliability of this tool as an indicator of risk has been questioned. The need for alternative, noninvasive surrogate markers is described in this report.

Citing Articles

A Compendium of Perspectives on Diabetes: A Challenge for Sustainable Health in the Modern Era.

Verma A, Goyal Y, Bhatt D, Dev K, Alsahli M, Rahmani A Diabetes Metab Syndr Obes. 2021; 14:2775-2787.

PMID: 34168477 PMC: 8216699. DOI: 10.2147/DMSO.S304751.

Diabetes Mellitus Is a Chronic Disease that Can Benefit from Therapy with Induced Pluripotent Stem Cells.

Arroyave F, Montano D, Lizcano F Int J Mol Sci. 2020; 21(22).

PMID: 33217903 PMC: 7698772. DOI: 10.3390/ijms21228685.

Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides.

Schanstra J, Zurbig P, Alkhalaf A, Argiles A, Bakker S, Beige J J Am Soc Nephrol. 2015; 26(8):1999-2010.

PMID: 25589610 PMC: 4520165. DOI: 10.1681/ASN.2014050423.

Mitochondrial dysfunction and mitophagy: the beginning and end to diabetic nephropathy?.

Higgins G, Coughlan M Br J Pharmacol. 2014; 171(8):1917-42.

PMID: 24720258 PMC: 3976613. DOI: 10.1111/bph.12503.

Combining genetic association study designs: a GWAS case study.

Estus J, Fardo D Front Genet. 2013; 4:186.

PMID: 24098305 PMC: 3784826. DOI: 10.3389/fgene.2013.00186.

References

Bangstad H, Osterby R, Dahl-Jorgensen K, Berg K, Hartmann A, Hanssen K . Improvement of blood glucose control in IDDM patients retards the progression of morphological changes in early diabetic nephropathy. Diabetologia. 1994; 37(5):483-90. DOI: 10.1007/s001250050136. View

Rossing K, Mischak H, Dakna M, Zurbig P, Novak J, Julian B . Urinary proteomics in diabetes and CKD. J Am Soc Nephrol. 2008; 19(7):1283-90. PMC: 2440301. DOI: 10.1681/ASN.2007091025. View

Torbjornsdotter T, Perrin N, Jaremko G, Berg U . Widening of foot processes in normoalbuminuric adolescents with type 1 diabetes. Pediatr Nephrol. 2005; 20(6):750-8. DOI: 10.1007/s00467-005-1829-5. View

. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group. Lancet. 1997; 349(9068):1787-92. View

Hovind P, Tarnow L, Rossing P, Jensen B, Graae M, Torp I . Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study. BMJ. 2004; 328(7448):1105. PMC: 406322. DOI: 10.1136/bmj.38070.450891.FE. View

Chavers B, MAUER S, RAMSAY R, Steffes M . Relationship between retinal and glomerular lesions in IDDM patients. Diabetes. 1994; 43(3):441-6. DOI: 10.2337/diab.43.3.441. View

Perkins B, Ficociello L, Silva K, Finkelstein D, Warram J, Krolewski A . Regression of microalbuminuria in type 1 diabetes. N Engl J Med. 2003; 348(23):2285-93. DOI: 10.1056/NEJMoa021835. View

Lachin J, Genuth S, Cleary P, Davis M, Nathan D . Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med. 2000; 342(6):381-9. PMC: 2630213. DOI: 10.1056/NEJM200002103420603. View

Mathiesen E, Hommel E, Hansen H, Smidt U, Parving H . Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria. BMJ. 1999; 319(7201):24-5. PMC: 28150. DOI: 10.1136/bmj.319.7201.24. View

10.

Forsblom C, Groop P, Ekstrand A, Groop L . Predictive value of microalbuminuria in patients with insulin-dependent diabetes of long duration. BMJ. 1992; 305(6861):1051-3. PMC: 1883577. DOI: 10.1136/bmj.305.6861.1051. View

11.

Mauer M, Drummond K . The early natural history of nephropathy in type 1 diabetes: I. Study design and baseline characteristics of the study participants. Diabetes. 2002; 51(5):1572-9. DOI: 10.2337/diabetes.51.5.1572. View

12.

Parving H, Hommel E, Mathiesen E, Skott P, Edsberg B, Bahnsen M . Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes. Br Med J (Clin Res Ed). 1988; 296(6616):156-60. PMC: 2544895. DOI: 10.1136/bmj.296.6616.156. View

13.

Steinke J, Sinaiko A, Kramer M, Suissa S, Chavers B, Mauer M . The early natural history of nephropathy in Type 1 Diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients. Diabetes. 2005; 54(7):2164-71. DOI: 10.2337/diabetes.54.7.2164. View

14.

Mathiesen E, Hommel E, Giese J, Parving H . Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. BMJ. 1991; 303(6794):81-7. PMC: 1670656. DOI: 10.1136/bmj.303.6794.81. View

15.

Fioretto P, Steffes M, Sutherland D, Mauer M . Sequential renal biopsies in insulin-dependent diabetic patients: structural factors associated with clinical progression. Kidney Int. 1995; 48(6):1929-35. DOI: 10.1038/ki.1995.493. View

16.

Amin R, Turner C, Van Aken S, Bahu T, Watts A, Lindsell D . The relationship between microalbuminuria and glomerular filtration rate in young type 1 diabetic subjects: The Oxford Regional Prospective Study. Kidney Int. 2005; 68(4):1740-9. DOI: 10.1111/j.1523-1755.2005.00590.x. View

17.

Zerbini G, Bonfanti R, Meschi F, Bognetti E, Paesano P, Gianolli L . Persistent renal hypertrophy and faster decline of glomerular filtration rate precede the development of microalbuminuria in type 1 diabetes. Diabetes. 2006; 55(9):2620-5. DOI: 10.2337/db06-0592. View

18.

Lewis E, Hunsicker L, Clarke W, Berl T, Pohl M, Lewis J . Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001; 345(12):851-60. DOI: 10.1056/NEJMoa011303. View

19.

Osterby R . Glomerular structural changes in type 1 (insulin-dependent) diabetes mellitus: causes, consequences, and prevention. Diabetologia. 1992; 35(9):803-12. DOI: 10.1007/BF00399925. View

20.

Lurbe E, Redon J, Pascual J, Tacons J, Alvarez V . The spectrum of circadian blood pressure changes in type I diabetic patients. J Hypertens. 2001; 19(8):1421-8. DOI: 10.1097/00004872-200108000-00010. View